DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
122 hedge funds and large institutions have $1.2B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 49 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
+37
Holders Change %
+43.53%
% of All Funds
2.68%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
47
Increased
49
Reduced
19
Closed
10
Calls
$5.44M
Puts
$8.87M
Net Calls
-$3.43M
Net Calls Change
+$16.3M
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
$83.5M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
$104M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
$272K |
| 4 |
SHI
SV Health Investors
Boston,
Massachusetts
|
$18.4M |
| 5 |
EP
Eversept Partners
New York
|
$747K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$56K | -2,476 | Closed |
|
|
QT
127
Quantamental Technologies
White Plains,
New York
| – | -$24K | -1,059 | Closed |
|
128
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$8K | -341 | Closed |
|
|
PCM
129
Prelude Capital Management
New York
| – | -$6K | -266 | Closed |
|
|
AG
130
Aperio Group
Sausalito,
California
| – | -$3K | -123 | Closed |
|